Sage Therapeutics Inc. sell Bank of America Co.
Start price
11.03.25
/
50%
€6.76
Target price
11.03.26
€4.61
Performance (%)
12.51%
Price
31.07.25
€7.60
Summary
This prediction is currently active. The prediction currently has a disappointing performance of 12.51%. This prediction currently runs until 11.03.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Sage Therapeutics Inc. | - | - |
| iShares Core DAX® | 0.396% | -0.010% |
| iShares Nasdaq 100 | 0.881% | -0.819% |
| iShares Nikkei 225® | 1.405% | -3.232% |
| iShares S&P 500 | 0.259% | -0.051% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Sage Therapeutics Inc. diskutieren
Sage Therapeutics, Inc. (NASDAQ: SAGE) is now covered by analysts at Bank of America Co.. They set an "underperform" rating and a $5.00 price target on the stock.
Ratings data for SAGE provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Sage Therapeutics Inc.
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€5.99
09.10.24
09.10.24
€5.48
09.10.25
09.10.25
26.80%
10.10.25
10.10.25
